The latest price and purchasing channels of bimekizumab in 2026

Bimekizumab (Bimekizumab) has not yet been included in medical insurance in China, but it is on the market and available for patients to purchase. According to current information, the domestic price of bichizumab injection is approximately RMB 3,000 to 4,000 per box (specification: 160mg*1 tube). This price is usually the standard pricing for imported drugs and is mainly affected by production costs, import tariffs, logistics and other factors. Because the drug is an imported original drug, the price is relatively high, and if it is not covered by the medical insurance policy, the patient needs to pay for it out of pocket when purchasing it.

Currently, there are two main ways for patients with plaque psoriasis to purchase bichizumab in China: one is through domestic authorized import channels or agents, and the other is to purchase directly through overseas markets. In overseas markets, especially Europe, the price of Biqizumab is higher. The price of 160mg*2 tubes is about RMB 40,000 to RMB 50,000. Affected by exchange rate fluctuations and international logistics costs, prices may fluctuate to a certain extent.

Although generic versions of drugs have not yet appeared at home or abroad, with the development of the field of biologics, generic drugs may be launched in the future. The emergence of generic drugs may promote price competition, allowing patients to obtain drug treatments at lower prices. At present, when domestic patients want to purchase bichizumab, in addition to choosing to purchase overseas, they also need to be cautious about the legality of the purchase channel and the authenticity of the drug to ensure that the purchased drug is of qualified quality and to avoid health risks caused by drugs of unknown origin.

In summary, bicizumab, as an imported original drug, has been widely used around the world because of its unique mechanism and significant efficacy in treating immune-mediated diseases. Although its price is relatively high, it still provides an effective treatment option for patients who are in urgent need of this drug.

Reference materials:https://www.drugs.com/bimekizumab.html